Radojka M Savic (Rada M Savic, Rada Savic)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 40

Top Topics

Pulmonary Tuberculosis

Mild Traumatic Brain Injury

Top Venues

Antimicrobial agents and chemotherapy

Nature communications

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
Janice J N Goh, Qianwen Wang, Nan Zhang, Niurys de Castro Suarez, Annamarie E Bustion, Eric L Nuermberger, Radojka M Savic
Prospectively predicting BPaMZ phase IIb/III trial outcomes using a translational mouse-to-human platform. Antimicrobial agents and chemotherapy (2024)
Segolene Simeon, Maria Garcia-Cremades, Radojka M Savic, Belen P Solans
Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrobial agents and chemotherapy 68 (8) (2024)
Segolene Simeon, Maria Garcia-Cremades, Radojka M Savic, Belen P Solans
Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrobial agents and chemotherapy 68 (8) (2024)
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial, Belen P Solans, Qianwen Wang, Rokeya Tasneen, Sandeep Tyagi, Heena Soni, Andrew Garcia, Kristina Bigelow, Martin Gengenbacher, Matthew Zimmerman, Min Xie, Jansy P Sarathy, Tian J Yang, Veronique Anne Dartois, Eric L Nuermberger, Radojka M Savic
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen. Nature communications 15 (1) (2024)
Segolene Simeon, Maria Garcia-Cremades, Radojka M Savic, Belen P Solans
Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrobial agents and chemotherapy 68 (8) (2024)
Segolene Simeon, Maria Garcia-Cremades, Radojka M Savic, Belen P Solans
Pharmacokinetic-pharmacodynamic modeling of tuberculosis time to positivity and colony-forming unit to assess the response to dose-ranging linezolid. Antimicrobial agents and chemotherapy (2024)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Ali Mohamed Ali, Kendra K Radtke, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Belen P Solans, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Anthony J Garcia-Prats, Radojka M Savic
QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies. Antimicrobial agents and chemotherapy (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Jacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob Christiaan van Wijk, Nan Zhang, Amelia Deitchman, Eric L Nuermberger, Radojka M Savic
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. The European respiratory journal (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy 67 (5) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Julie Bertrand, Aurélie Barrail-Tran, Lucie Fayette, Radojka M Savic, Cécile Goujard, Elina Teicher, Caroline Barau, Alain Pruvost, Anne-Marie Taburet, France Mentré, Céline Verstuyft
Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records. Antimicrobial agents and chemotherapy (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy (2023)
Ali Mohamed Ali, Belen P Solans, Anneke C Hesseling, Jana Winckler, H Simon Schaaf, Heather R Draper, Louvina E van der Laan, Jennifer Hughes, Barend Fourie, James Nielsen, Lubbe Wiesner, Anthony J Garcia-Prats, Radojka M Savic
Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (1) (2023)
Nicholas D Walter, Jackie P Ernest, Christian Dide-Agossou, Allison A Bauman, Michelle E Ramey, Karen Rossmassler, Lisa M Massoudi, Samantha Pauly, Reem Al Mubarak, Martin I Voskuil, Firat Kaya, Jansy P Sarathy, Matthew D Zimmerman, Veronique Anne Dartois, Brendan K Podell, Radojka M Savic, Gregory Thomas Robertson
Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses. Antimicrobial agents and chemotherapy (2023)
William S Fox, Natasha Strydom, Marjorie Z Imperial, Leah G Jarsberg, Radojka M Savic
Examining nonadherence in the treatment of tuberculosis: The patterns that lead to failure. British journal of clinical pharmacology (2022)
Firat Kaya, Jacqueline P Ernest, Katherine LoMauro, Martin Gengenbacher, Abdeldjalil Madani, Wassihun Wedajo Aragaw, Matthew D Zimmerman, Jansy P Sarathy, Nadine Alvarez, Isaac Daudelin, Han Wang, Faye Lanni, Danielle M Weiner, Laura E Via, Clifton E Barry, Kenneth N Olivier, Thomas Dick, Brendan K Podell, Radojka M Savic, Veronique Anne Dartois
A Rabbit Model to Study Antibiotic Penetration at the Site of Infection for Nontuberculous Mycobacterial Lung Disease: Macrolide Case Study. Antimicrobial agents and chemotherapy 66 (3) (2022)
Hwi-Yeol Yun, Min Jung Chang, Heeyoon Jung, Vincent Chang, Qianwen Wang, Natasha Strydom, Young-Ran Yoon, Radojka M Savic
Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy 66 (9) (2022)
Christian Dide-Agossou, Allison A Bauman, Michelle E Ramey, Karen Rossmassler, Reem Al Mubarak, Samantha Pauly, Martin I Voskuil, Maria Garcia-Cremades, Radojka M Savic, Payam Nahid, Camille M Moore, Rokeya Tasneen, Eric L Nuermberger, Gregory Thomas Robertson, Nicholas D Walter
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrobial agents and chemotherapy 66 (4) (2022)
Emmanuel Musisi, Christian Dide-Agossou, Reem Al Mubarak, Karen Rossmassler, Abdul Wahab Ssesolo, Sylvia Kaswabuli, Patrick Byanyima, Ingvar Sanyu, Josephine Zawedde, William Worodria, Martin I Voskuil, Radojka M Savic, Payam Nahid, John Lucian Davis, Laurence Huang, Camille M Moore, Nicholas D Walter
Reproducibility of the Ribosomal RNA Synthesis Ratio in Sputum and Association with Markers of Mycobacterium tuberculosis Burden. Microbiology spectrum 9 (2) (2021)
Erika K Wallender, Ali Mohamed Ali, Emma Hughes, Abel Kakuru, Prasanna Jagannathan, Mary Kakuru Muhindo, Bishop Opira, Meghan Whalen, Liusheng Huang, Marvin Duvalsaint, Jenny Legac, Moses R Kamya, Grant Dorsey, Francesca Aweeka, Philip J Rosenthal, Radojka M Savic
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children. Nature communications 12 (1) (2021)
Marjorie Z Imperial, Patrick Peter John Phillips, Payam Nahid, Radojka M Savic
Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials. American journal of respiratory and critical care medicine 204 (9) (2021)
Nicholas D Walter, Sarah E M Born, Gregory T Robertson, Matthew Reichlen, Christian Dide-Agossou, Victoria A Ektnitphong, Karen Rossmassler, Michelle E Ramey, Allison A Bauman, Victor Ozols, Shelby C Bearrows, Gary Schoolnik, Gregory Dolganov, Benjamin J Garcia, Emmanuel Musisi, William Worodria, Laurence Huang, John Lucian Davis, Nhung V Nguyen, Hung V Nguyen, Anh T V Nguyen, Ha Phan, Carol Wilusz, Brendan K Podell, C N'Dira Sanoussi, Bouke Catherine de Jong, Corinne S Merle, Dissou Affolabi, Helen McIlleron, Maria Garcia-Cremades, Ekaterina Maidji, Franceen Eshun-Wilson, Brandon Aguilar-Rodriguez, Dhuvarakesh Karthikeyan, Khisimuzi Mdluli, Cathy Bansbach, Anne J Lenaerts, Radojka M Savic, Payam Nahid, Joshua J Vásquez, Martin I Voskuil
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens. Nature communications 12 (1) (2021)
Andrew D Gewitz, Belén P Solans, William R Mac Kenzie, Chad Heilig, William C Whitworth, John L Johnson, Pheona Nsubuga, Susan Dorman, Marc Weiner, Radojka M Savic, null null
Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis. Antimicrobial agents and chemotherapy 65 (10) (2021)
Jacqueline P Ernest, Jansy Sarathy, Ning Wang, Firat Kaya, Matthew D Zimmerman, Natasha Strydom, Han Wang, Min Xie, Martin Gengenbacher, Laura E Via, Clifton E Barry, Claire L Carter, Radojka M Savic, Veronique Anne Dartois
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis. Antimicrobial agents and chemotherapy 65 (10) (2021)
Kendra K Radtke, Jacqueline P Ernest, Nan Zhang, Nicole C Ammerman, Eric L Nuermberger, Robert Belknap, Rosanna Boyd, Timothy R Sterling, Radojka M Savic
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study. Antimicrobial agents and chemotherapy 65 (12) (2021)
John Fors, Natasha Strydom, William S Fox, Ron J Keizer, Radojka M Savic
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis. PLoS computational biology 16 (8) (2020)
Emma Hughes, Marjorie Imperial, Erika K Wallender, Richard Kajubi, Liusheng Huang, Prasanna Jagannathan, Nan Zhang, Abel Kakuru, Paul Natureeba, Moses W Mwima, Mary Muhindo, Norah Mwebaza, Tamara D Clark, Bishop Opira, Miriam Nakalembe, Diane Havlir, Moses Kamya, Philip J Rosenthal, Grant Dorsey, Francesca Aweeka, Radojka M Savic
Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan Women. Antimicrobial agents and chemotherapy 64 (12) (2020)
Anthony J Garcia-Prats, H Simon Schaaf, Heather R Draper, Maria Garcia-Cremades, Jana Winckler, Lubbe Wiesner, Anneke C Hesseling, Radojka M Savic
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies. PLoS medicine 16 (4) (2019)
Natasha Strydom, Sneha V Gupta, William S Fox, Laura E Via, Hyeeun Bang, Myungsun Lee, Seokyong Eum, Tae Sun Shim, Clifton Earl Barry, Matthew Zimmerman, Veronique Anne Dartois, Radojka M Savic
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization. PLoS medicine 16 (4) (2019)
Marjorie Z Imperial, Payam Nahid, Patrick P J Phillips, Geraint R Davies, Katherine Fielding, Debra Hanna, David Hermann, Robert S Wallis, John L Johnson, Christian Lienhardt, Radojka M Savic
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nature medicine 24 (11) (2018)